Document Detail

Cardiovascular gene therapy for myocardial infarction.
MedLine Citation:
PMID:  24328708     Owner:  NLM     Status:  Publisher    
Introduction: Cardiovascular gene therapy is the third most popular application for gene therapy, representing 8.4% of all gene therapy trials as reported in 2012 estimates. Gene therapy in cardiovascular disease is aiming to treat heart failure from ischemic and non-ischemic causes, peripheral artery disease, venous ulcer, pulmonary hypertension, atherosclerosis and monogenic diseases, such as Fabry disease. Areas covered: In this review, we will focus on elucidating current molecular targets for the treatment of ventricular dysfunction following myocardial infarction (MI). In particular, we will focus on the treatment of i) the clinical consequences of it, such as heart failure and residual myocardial ischemia and ii) etiological causes of MI (coronary vessels atherosclerosis, bypass venous graft disease, in-stent restenosis). Expert opinion: We summarise the scheme of the review and the molecular targets either already at the gene therapy clinical trial phase or in the pipeline. These targets will be discussed below. Following this, we will focus on what we believe are the 4 prerequisites of success of any gene target therapy: safety, expression, specificity and efficacy (SESE).
Maria C Scimia; Anna M Gumpert; Walter J Koch
Related Documents :
8462708 - Cardiac risk screening of peripheral arterial surgical patients by the use of combined ...
20832878 - The impact of early compared to late morning hours on brachial endothelial function and...
15668368 - Renovascular disease and the risk of adverse coronary events in the elderly: a prospect...
16513518 - Utilization efficacy of noninvasive and invasive cardiac testing among stable cardiac p...
16092578 - Outcomes among valvular heart disease patients experiencing ischemic stroke or transien...
1495148 - Intraoperative arteriography and carotid surgery.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-12-16
Journal Detail:
Title:  Expert opinion on biological therapy     Volume:  -     ISSN:  1744-7682     ISO Abbreviation:  Expert Opin Biol Ther     Publication Date:  2013 Dec 
Date Detail:
Created Date:  2013-12-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101125414     Medline TA:  Expert Opin Biol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Absolute Determination of Single-Stranded and Self-Complementary AAV Vector Genome Titers by Droplet...
Next Document:  Organ-Specific Solutions and Strategies for the Intestinal Preservation.